Yıl: 2022 Cilt: 2 Sayı: 3 Sayfa Aralığı: 54 - 58 Metin Dili: İngilizce DOI: 10.14744/eer.2022.79188 İndeks Tarihi: 21-05-2023

End stage thyroid ophthalmopathy presenting with bilateral exposure keratitis

Öz:
The present case reports a 70-year-old female patient who presented with bilateral exophthalmos, lagophthalmus, and ex- posure keratitis. An aggressive topical treatment was commenced that included fortified vancomycin and ceftazidime. She was subsequently diagnosed with severe thyroid ophthalmopathy (TO) due to severe static and dynamic tremor that raised suspicion and abnormal thyroid function tests indicating Graves’ Disease. She was diagnosed with bilateral exposure keratitis secondary to TO in which the clinical activity score was assessed as 5. As her TO was sight-threatening, she was administered intravenous pulse methylprednisolone, followed by bilateral balanced 2-wall (medial and lateral) decompression and lateral temporary tarsorrhaphy surgeries. As her exophthalmos and lagophthalmos improved postoperatively, both eyes’ keratitis significantly regressed, and left scar tissue in the cornea. This extreme case should raise awareness for clinicians in the eti- ological investigation of exposure keratopathy to identify sight-threatening thyroid ophthalmopathy and promptly initiate appropriate treatment.
Anahtar Kelime: Exposure keratitis thyroid ophthalmopathy thyroid orbitopathy.

Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
  • Demirel S, Cumurcu T, Firat P, Aydogan MS, Doganay S. Effective management of exposure keratopathy developed in intensive care units: The impact of an evidence based eye care education programme. Intensive Crit Care Nurs 2014;30:38–44.
  • Hodgson NM, Rajaii F. Current understanding of the progres- sion and management of thyroid associated orbitopathy: A systematic review. Ophthalmol Ther 2020;9:21–33.
  • Kuruvilla S, Peter J, David S, Premkumar PS, Ramakrishna K, Thomas L, et al. Incidence and risk factor evaluation of expo- sure keratopathy in critically ill patients:A cohort study. J Crit Care 2015;30:400–4.
  • Grixti A, Sadri M, Edgar J, Datta AV. Common ocular surface disorders in patients in intensive care units. Ocul Surf 2012;10:26–42.
  • Gupta R, Thomas R, Almukhtar F, Kiran A. Visual morbidity in thyroid eye disease in Asian Indian patients. Indian J Ophthal- mol 2020;68:1622–7.
  • Mizokami T, Li AW, El-Kaissi S, Wall JR. Stress and thyroid auto- immunity. Thyroid 2004;14:1047–55.
  • Barrio-Barrio J, Sabater AL, Bonet-Farriol E, Velazquez-Villoria A, Galofre JC. Graves’ ophthalmopathy: VISA versus EUGOGO classification, assessment, and management. J Ophthalmol 2015;2015:249125.
  • Latkany RL, Lock B, Speaker M. Nocturnal lagophthalmos: An overview and classification. Ocul Surf 2006;4:44–53.
  • Alhoutan K, Alarfaj K. Exposure keratopathy: An ıdiopathic lagophthalmos case report. Cureus 2021;13:e18945.
  • Sohrab M, Abugo U, Grant M, Merbs S. Management of the eye in facial paralysis. Facial Plast Surg 2015;31:140–4.
  • Sacchetti M, Lambiase A. Diagnosis and management of neu- rotrophic keratitis. Clin Ophthalmol 2014;8:571–9.
  • West SD, Turnbull C. Eye disorders associated with obstructive sleep apnoea. Curr Opin Pulm Med 2016;22:595–601.
APA Akbulut Yagci B, Utine C, Yaman A (2022). End stage thyroid ophthalmopathy presenting with bilateral exposure keratitis. , 54 - 58. 10.14744/eer.2022.79188
Chicago Akbulut Yagci Betul,Utine Canan A,Yaman Aylin End stage thyroid ophthalmopathy presenting with bilateral exposure keratitis. (2022): 54 - 58. 10.14744/eer.2022.79188
MLA Akbulut Yagci Betul,Utine Canan A,Yaman Aylin End stage thyroid ophthalmopathy presenting with bilateral exposure keratitis. , 2022, ss.54 - 58. 10.14744/eer.2022.79188
AMA Akbulut Yagci B,Utine C,Yaman A End stage thyroid ophthalmopathy presenting with bilateral exposure keratitis. . 2022; 54 - 58. 10.14744/eer.2022.79188
Vancouver Akbulut Yagci B,Utine C,Yaman A End stage thyroid ophthalmopathy presenting with bilateral exposure keratitis. . 2022; 54 - 58. 10.14744/eer.2022.79188
IEEE Akbulut Yagci B,Utine C,Yaman A "End stage thyroid ophthalmopathy presenting with bilateral exposure keratitis." , ss.54 - 58, 2022. 10.14744/eer.2022.79188
ISNAD Akbulut Yagci, Betul vd. "End stage thyroid ophthalmopathy presenting with bilateral exposure keratitis". (2022), 54-58. https://doi.org/10.14744/eer.2022.79188
APA Akbulut Yagci B, Utine C, Yaman A (2022). End stage thyroid ophthalmopathy presenting with bilateral exposure keratitis. European eye research, 2(3), 54 - 58. 10.14744/eer.2022.79188
Chicago Akbulut Yagci Betul,Utine Canan A,Yaman Aylin End stage thyroid ophthalmopathy presenting with bilateral exposure keratitis. European eye research 2, no.3 (2022): 54 - 58. 10.14744/eer.2022.79188
MLA Akbulut Yagci Betul,Utine Canan A,Yaman Aylin End stage thyroid ophthalmopathy presenting with bilateral exposure keratitis. European eye research, vol.2, no.3, 2022, ss.54 - 58. 10.14744/eer.2022.79188
AMA Akbulut Yagci B,Utine C,Yaman A End stage thyroid ophthalmopathy presenting with bilateral exposure keratitis. European eye research. 2022; 2(3): 54 - 58. 10.14744/eer.2022.79188
Vancouver Akbulut Yagci B,Utine C,Yaman A End stage thyroid ophthalmopathy presenting with bilateral exposure keratitis. European eye research. 2022; 2(3): 54 - 58. 10.14744/eer.2022.79188
IEEE Akbulut Yagci B,Utine C,Yaman A "End stage thyroid ophthalmopathy presenting with bilateral exposure keratitis." European eye research, 2, ss.54 - 58, 2022. 10.14744/eer.2022.79188
ISNAD Akbulut Yagci, Betul vd. "End stage thyroid ophthalmopathy presenting with bilateral exposure keratitis". European eye research 2/3 (2022), 54-58. https://doi.org/10.14744/eer.2022.79188